Economic Implications of Optimal Diagnosis and Treatment of Sepsis – Work in Progress: Marginal Penalties, Antibiotic Alterations, and Outcome Hypotheses

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 63, Issue sup239, 2003, Pages 16-26

  Kost, Gerald J ^a   Tang, Zuping ^b   Tran, Nam K ^c   Curd, Emily E ^d   Louie, Richard F ^a   Albertson, Timothy E ^b   Derlet, Robert W ^c   Azari, Rahman ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Depts of Medicine and Physiology   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alteration debt; and therapeutic turnaround time (TTAT); cost effectiveness; frame shift; length of stay (LOS); multiple organ dysfunction syndrome (MODS); nucleic acid testing; pathogen; systemic inflammatory response syndrome (SIRS); value analysis; value proposition; value strategy

Indexed keywords

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTIFICIAL VENTILATION; BLOOD CULTURE; BLOOD SAMPLING; CATHETERIZATION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ECONOMIC ASPECT; FEMALE; HUMAN; INTENSIVE CARE; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICROBIAL IDENTIFICATION; MORTALITY; NUCLEIC ACID TEST; PRIORITY JOURNAL; SEPSIS; SEPTICEMIA; TRACHEOSTOMY;

EID: 0043234608     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00855910310002196     Document Type: Article

References (22)

1. Balk RA, Ely EW, Goyette RE. Sepsis Hand-book / National Initiative In Sepsis Education (NISE). Vanderbilt University Medical Center: National Initiative in Sepsis Education, 2001.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemi-ology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303 – 1310.
3. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infec-tions: A risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462 – 474.
4. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antim-icrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146 – 155.
5. Kost GJ, Tran NK, Louie RF, Tang Z, Wood-ruff AA, Albertson AE, Derlet RW, Azari A. Rapid diagnosis of sepsis: Point-of-care testing, nucleic acid testing, and the value model. Point of Care: The Journal of Near-Patient Testing and Technology. 2003; In Press.
6. Kost GJ. Controlling economics, preventing errors, and optimising outcomes in point-of-care testing. In: Kost GJ, ed. Principles & Prac-tice of Point-of-Care Testing. Philadelphia: Lippincott Williams & Wilkins; Chapter 40, 2002: 577 – 600.
7. Oinonen MJ, Ratko TA, Cummings JP, Matuszewski KA. Antimicrobial central venous catheters: A qualitative review of the literature and economic assessment. JCOM 2000; 7: 42 – 48.
8. DiGiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of pri-mary nosocomial blood stream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160: 976 – 981.
9. Bowen CP, Whitney LR, Truwit JD, Durbin CG, Moore MM. Comparison of safety and cost of percutaneous versus surgical tracheo-stomy. Am Surg 2001; 67: 54 – 60.
10. McCormick AW, Whitney CG, Farley MM, Lynfield R, Harrison LH, Bennett NM, Schaff-ner W, Reingold A, Hadler J, Cieslak P, Samore MH, Lipsitch M. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States.Nature Medicine(onlinewww.nature.cominaturemedicine) 3 March 2003.
11. Leone M, Bourgoin A, Cambon S, Dubuc M, Albanese J, Martin C. Empirical antimicrobial therapy of septic shock patients: Adequacy and impact on outcome. Crit Care Med 2003; 31: 462 – 467.
12. Kost GJ. The hybrid laboratory: Therapeutic turnaround time, critical limits, performance maps, and Knowledge Optimization®. In: Kost GJ, ed. Principles & Practice of Point-of-Care Testing. Philadelphia: Lippincott Williams & Wilkins; Chapter 2, 2002: 13 – 25.
13. Griffith JR, Alexander JA, Jelinek RC. Measur-ing comparative hospital performance. J Healthcare Management 2002; 47 (1): 41 – 57.
14. Battleman DS, Callahan M, Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of stay of patients with community-acquired pneumonia; link between quality of care and resource utilization. Arch Int Med 2002; 162: 682 – 687.
15. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122: 262 – 268.
16. Letarte J, Longo CJ, Pelletier J, Naboone B, Fisher HN. Patient characteristics and costs of severe sepsis and septic shock in Quebec. J Crit Care 2002; 17: 39 – 49.
17. Hamel MB, Phillips RS, Davis RB, Teno J, Connors AF, Desbiens N, Lynn J, Dawson NV, Fulkerson W, Tsevat J. Outcomes and cost-effectiveness of ventilator support and aggres-sive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome. Am J Med 2000; 109: 614 – 620.
18. Logsdon BA, Casto DT. Prevention of group B streptococcus infection in neonates. Ann Phar-macother 1997; 31: 897 – 906.
19. Fagon J-Y, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, Similowski T, Mer-cat A, Diehl J-L, Sollet J-P, Tenaillon A. Inva-sive and noninvasive strategies for manage-ment of suspected ventilator-associated pneu-monia: A randomized trial. Ann Intern Med 2000; 132: 621 – 630.
20. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. Ann J Respir Crit Care Med 2000; 162: 505 – 511.
21. Rosenman M, Madsen K, Hui S, Breitfeld PP. Modeling administrative outcomes in fever and neutropenia: clinical variables significantly in-fluence length of stay and hospital charges. J Pediatr Hem Onc 2002; 24: 263 – 268.
22. Van Den Berghe G, Wouters P, Verwaest C, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Bouillon R. Intensive insulin therapy in critical ill patients. N Engl J Med 2001; 345: 1359 – 67.